PRESS RELEASE published on 06/05/2024 at 22:30, 2 years 1 month ago DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference DBV Technologies to participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10th, featuring CEO Daniel Tassé in a fireside chat and investor meetings. Live webcast available online Biopharmaceutical DBV Technologies Food Allergies Goldman Sachs Global Healthcare Conference Daniel Tassé
BRIEF published on 06/04/2024 at 22:35, 2 years 1 month ago DBV Technologies Reports Voting Rights and Shares Information as of May 31, 2024 Voting Rights Shares AMF Regulations DBV Technologies
PRESS RELEASE published on 06/04/2024 at 22:30, 2 years 1 month ago Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024 Press release providing information on the total number of voting rights and shares of the Company as of May 31, 2024, in compliance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers Voting Rights Shares AMF Company NYSE Euronext Paris
BRIEF published on 05/31/2024 at 15:56, 2 years 1 month ago DBV Technologies Announces Plan to Implement ADS Ratio Change Nasdaq Compliance Biopharmaceutical Reverse Split DBV Technologies ADS Ratio
PRESS RELEASE published on 05/31/2024 at 15:51, 2 years 1 month ago DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies announces plan to change ADS Ratio to regain Nasdaq compliance effective June 7th, 2024, impacting ADS holders trading price Biopharmaceutical Company Nasdaq Compliance DBV Technologies ADS Ratio Change Food Allergies Treatment
BRIEF published on 05/17/2024 at 22:35, 2 years 2 months ago DBV Technologies Announces ADS Ratio Change Nasdaq Compliance Biopharmaceuticals Stock Adjustment DBV Technologies ADS Ratio Change
PRESS RELEASE published on 05/17/2024 at 22:30, 2 years 2 months ago DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies announces plan to change ADS Ratio to regain Nasdaq compliance. The ADS Ratio Change will be effective on June 3rd, 2024, impacting ADS trading price. No impact on underlying ordinary shares Ordinary Shares Nasdaq Compliance DBV Technologies ADS Ratio Change Trading Price
BRIEF published on 05/16/2024 at 22:35, 2 years 2 months ago DBV Technologies announces the results of the 2024 Combined General Meeting General Assembly 2024 DBV Technologies Resolutions Adopted Allergy Treatment Biopharmaceutical Sector
PRESS RELEASE published on 05/16/2024 at 22:30, 2 years 2 months ago DBV Technologies Announces Results of its 2024 Combined General Meeting DBV Technologies announces successful results of its 2024 Combined General Meeting where shareholders approved all proposed resolutions. The Company focuses on treatment options for food allergies Resolutions Combined General Meeting DBV Technologies Food Allergies Treatment Options
BRIEF published on 05/09/2024 at 22:35, 2 years 2 months ago DBV Technologies announces its participation in two investor conferences in May DBV Technologies Food Allergy JMP Life Sciences HC Wainwright BioConnect Conference Webcast
Published on 07/30/2026 at 04:10, 7 hours 39 minutes ago Pathfinder Ventures Announces Appointment of Mark Roseborough as Chief Executive Officer
Published on 07/30/2026 at 01:50, 9 hours 59 minutes ago Further Assays Infill Tunkillia Pit Extension Targets
Published on 07/30/2026 at 00:50, 10 hours 59 minutes ago Aton Announces Strategic Cooperation Relationship and Board Nominee
Published on 07/30/2026 at 00:00, 11 hours 49 minutes ago American Hotel Income Properties REIT LP to Host Second Quarter 2026 Results Conference Call on August 6, 2026
Published on 07/29/2026 at 23:01, 12 hours 48 minutes ago Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
Published on 07/30/2026 at 11:08, 41 minutes ago OHB Italia awarded contract for PRISMA Second Generation satellite
Published on 07/30/2026 at 11:05, 44 minutes ago VT Markets Reports Record-High Trading Volume of $8 Trillion
Published on 07/30/2026 at 11:05, 44 minutes ago Fenarrio Brings a Smarter Approach to Modern Parenting Across Europe
Published on 07/30/2026 at 11:05, 44 minutes ago End High Return Rates: Headwolf Launches Privacy-First AI Eyewear & Recorders for European Professionals
Published on 07/30/2026 at 11:00, 49 minutes ago ABB Ltd: ABB share buybacks - July 23, 2026 - July 29, 2026
Published on 07/30/2026 at 09:07, 2 hours 42 minutes ago CNP Assicura, a subsidiary of CNP Assurances in Italy, announces an exclusive partnership with Fineco bank in the life insurance segment
Published on 07/30/2026 at 07:30, 4 hours 19 minutes ago Availability of the 2026 Interim Financial Report
Published on 07/30/2026 at 07:30, 4 hours 19 minutes ago Half-year 2026: Accor shows its agility in a challenging global environment
Published on 07/30/2026 at 07:00, 4 hours 49 minutes ago Mersen 2026 guidance raised after strong momentum in the first half